B12 injections are genuinely necessary for some people and irrelevant for most. The dividing line is absorption, not intake. This guide covers who is actually deficient, why intrinsic factor is the bottleneck, what the oral-versus-injection trials found, and what happens when you supplement a level that was already normal.
Metabolic Support
Published by Astra, which offers some of the treatments discussed. Educational, not medical advice.
Vitamin B12, cobalamin, is a cofactor for two enzymatic reactions in humans. One converts homocysteine to methionine, which feeds methylation reactions across the body including DNA synthesis. The other converts methylmalonyl-CoA to succinyl-CoA in mitochondrial energy metabolism. Both matter, and both fail quietly.
Because DNA synthesis is affected, the fastest-dividing cells complain first, which is why megaloblastic anemia is the classic hematologic sign. The nervous system is the other major target: B12 deficiency causes peripheral neuropathy and, when prolonged, subacute combined degeneration of the spinal cord.1 Neurological damage from prolonged deficiency can be permanent, which is why the condition is worth catching rather than watching.
Deficiency develops slowly. The liver stores enough B12 to last years, so a person who stops absorbing it today may not become symptomatic for two to five years. That lag is the reason deficiency is so often found late and so often mistaken for fatigue, aging, or something else.
The comprehensive review of vitamin B12 deficiency identifies the populations where risk is genuinely elevated.1 Older adults are the largest, mainly through atrophic gastritis, which reduces stomach acid and impairs the release of B12 from food protein. Estimates of low or borderline B12 in older adults run into the double digits by percentage in multiple populations.
Pernicious anemia, an autoimmune condition destroying the gastric parietal cells that make intrinsic factor, is the classic cause and the one that genuinely requires lifelong replacement. Gastric surgery, including bariatric procedures, and ileal resection or Crohn's disease affecting the terminal ileum both remove parts of the absorption pathway anatomically.
Two medication groups matter. Long-term metformin use is associated with reduced B12 levels, and long-term proton pump inhibitor or H2 blocker use reduces the acid needed to liberate food-bound B12. Both are common enough that they account for a large share of the deficiency clinicians see.
Dietary deficiency is real but narrower than it is marketed. B12 occurs naturally only in animal foods, so vegans and strict vegetarians who do not supplement will eventually deplete, as will their breastfed infants. An omnivore with a working gut is rarely deficient from diet alone.
What is not on that list: general tiredness, wanting more energy, or being in a phase of life that feels demanding. Fatigue is a nonspecific symptom with a long differential, and B12 is one line in it. The intervention that helps a deficient person does nothing measurable for a replete one.
Normal B12 absorption is an elaborate relay. Stomach acid and pepsin free B12 from food protein. Haptocorrin from saliva binds it through the stomach. In the duodenum, pancreatic enzymes transfer it to intrinsic factor, a glycoprotein secreted by gastric parietal cells. The intrinsic factor complex then travels to the terminal ileum, where a specific receptor takes it up.1
Every step is a possible point of failure, and the receptor-mediated route saturates. It can move only a limited amount of B12 per meal regardless of how much is present, which is why eating more liver does not rescue someone with pernicious anemia.
There is a second, unglamorous route: roughly 1 percent of an oral dose crosses the intestinal wall by passive diffusion, requiring no intrinsic factor and no receptor.2 It is inefficient, and it is also the entire basis of high-dose oral therapy. Give 1,000 to 2,000 micrograms orally and that 1 percent is 10 to 20 micrograms, which comfortably exceeds daily requirements even when the normal pathway is completely broken.
This is where the honest answer runs against the intuition that an injection must be stronger. A Cochrane review compared oral vitamin B12 with intramuscular vitamin B12 for B12 deficiency and found that high-dose oral therapy was comparably effective at normalizing serum B12 and hematologic markers in the trials available, though the evidence base was small and of limited quality.2
A later systematic review and meta-analysis of sublingual and oral versus intramuscular administration reached a consistent conclusion: the oral and sublingual routes achieved comparable biochemical correction in the populations studied.3
Read the caveats with the conclusion. These trials were mostly small, mostly measured biochemical rather than long-term clinical endpoints, and largely enrolled adults who were able to swallow and adhere to a daily tablet. They do not settle every case.
Injection remains the better route in specific situations: severe deficiency with neurological signs where rapid, guaranteed repletion matters; patients who cannot reliably take a daily oral dose; malabsorption severe enough to make even passive diffusion unreliable; and clinical contexts where confirming that the dose was actually delivered is important. Adherence is a legitimate clinical reason, not a lesser one. A monthly injection that happens beats a daily tablet that does not.
What the evidence does not support is presenting injections as categorically superior for everyone. For most people with straightforward deficiency, high-dose oral works.
B12 is water-soluble, and excess is largely excreted, which is where the reasoning usually stops: no harm, so why not. That is a weaker argument than it sounds.
A review asking directly whether more B12 supplementation is always better concluded that it is not, and that supplementing beyond repletion lacks demonstrated benefit while observational associations between high B12 levels and adverse outcomes deserve attention rather than dismissal.4 Elevated serum B12 in the absence of supplementation is itself a recognised clinical flag, associated in cohort data with liver disease and malignancy, which is a reason to interpret a high level rather than celebrate it.
The practical implication is simple and slightly unfashionable: test before treating. A serum B12 with methylmalonic acid or homocysteine when the result is borderline will tell you whether there is anything to correct. If the level is normal and you feel tired, the tired is coming from somewhere else, and the useful work is finding out where.
The interesting question about B12 is never how much you consume. It is whether your gut can move it across, and whether your level was low to begin with.
Astra Editorial
They resolve the fatigue caused by B12 deficiency. If you are not deficient, there is no evidence that additional B12 increases energy.
For most people with deficiency, high-dose oral B12 corrects the deficiency comparably to intramuscular dosing in the available trials. Injections are preferred for severe deficiency with neurological signs, unreliable adherence, or significant malabsorption.
Older adults with atrophic gastritis, people with pernicious anemia, those on long-term metformin or acid suppression, people after gastric or ileal surgery, and vegans or strict vegetarians who do not supplement.
Yes. A serum B12 level, with methylmalonic acid or homocysteine if the result is borderline, tells you whether there is a deficiency to treat.
Compounded Lipo MIC + B12 — online evaluation. Only charged if prescribed. If you have a reason to think you are deficient, testing comes first. A licensed physician reviews your history and labs before anything is prescribed.
This guide is educational and is not medical advice. Compounded medications are not FDA-approved. Speak with a licensed physician about your own care.